Ono Pharmaceutical Co., Ltd. - SIC # 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS SUNDRIES

Ticker Exchange SIC # Website Latest Ticker
OPHLY Over the counter 5122 www.ono-pharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ono Pharmaceutical Co., Ltd.

Deciphera Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 INTREPID Study of Sapablursen in Polycythemia Vera - Jun 17th, 2026 5:00 am
Thyroid Cancer (TC) Market View Report 2026: Ipsen/Exelixis, Ono Pharmaceutical, and Novartis Dominate the Treatment Landscape - May 6th, 2026 3:11 am
Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight - Apr 22nd, 2026 11:00 am
Why Ionis Pharmaceuticals’ (IONS) 2026 Catalyst Pipeline Supported Leerink’s Higher Target - Mar 18th, 2026 8:13 am
Ono Pharmaceutical (TSE:4528) Valuation Check As New Neurology And Rare Disease Partnerships Advance - Mar 5th, 2026 6:11 pm
Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs - Mar 2nd, 2026 3:00 pm
Needham Lifts PT on Ionis Pharmaceuticals (IONS) to $103 From $90 - Feb 26th, 2026 9:53 pm
Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical - Jan 7th, 2026 3:00 am
Has Ono Pharmaceutical’s 2025 Share Price Rally Left Limited Upside? - Dec 8th, 2025 8:10 pm
Portal Hypertension Drugs Market Research Report 2025-2035: Key Dynamics, Pipeline Analysis, Regulatory Landscape, Epidemiology - Nov 19th, 2025 6:54 am
PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. - Nov 14th, 2025 1:00 am
Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment - Oct 6th, 2025 12:00 am
Is Now the Right Moment for Ono Pharmaceutical Shares Amid Sector Recovery in 2025? - Sep 9th, 2025 7:22 am